ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

Bioassay Report Clears EDTA

August 12, 1977

Also NCI requests $6.2 billion in FY2005 Bypass Budget.

January 2, 2004

Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.

February 25, 2000

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997

ASSIST evaluation finds proven methods help states fight tobacco.

December 5, 2003